Summary
Aethlon Medical Inc (Aethlon Medical) is a developer of immunotherapeutic technologies for the treatment of infectious diseases and cancer. The company’s lead product, Hemopurifier, strengthens natural immunity in human immunodeficiency virus and hepatitis C virus infected patients. Its other pipeline products include HER2osome, for combating HER2+ breast cancer; and ELLSA exosome assay, which is an enzyme linked lectin specific assay to identify and quantify the presence of exosomes in HIV, HCV and tuberculosis. The company is also developing a medical device under the DARPA Sepsis program. Aethlon harnesses its ADAPT system to develop infrastructure of dialysis machines and CRRT systems in hospitals and clinics. Aethlon Medical is headquartered in San Diego, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Aethlon Medical Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Aethlon Medical Inc Company Overview 4
Aethlon Medical Inc Company Snapshot 4
Aethlon Medical Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Aethlon Medical Inc – Pipeline Analysis Overview 7
Business Description 7
Aethlon Medical Inc - Key Facts 8
Aethlon Medical Inc - Major Products and Services 9
Aethlon Medical Inc Pipeline Products by Development Stage 10
Aethlon Medical Inc Ongoing Clinical Trials by Trial Status 12
Aethlon Medical Inc Pipeline Products Overview 14
ASEPSYS Device 14
ASEPSYS Device Product Overview 14
Diagnostic Test - Chronic Traumatic Encephalopathy 15
Diagnostic Test - Chronic Traumatic Encephalopathy Product Overview 15
Diagnostic Test - Chronic Traumatic Encephalopathy Clinical Trial 16
ELLSA Exosome Assay 17
ELLSA Exosome Assay Product Overview 17
Hemopurifier 18
Hemopurifier Product Overview 18
Hemopurifier Clinical Trial 19
HER2osome 20
HER2osome Product Overview 20
Aethlon Medical Inc - Key Competitors 21
Aethlon Medical Inc - Key Employees 22
Aethlon Medical Inc - Key Employee Biographies 23
Aethlon Medical Inc - Locations And Subsidiaries 24
Head Office 24
Other Locations & Subsidiaries 24
Recent Developments 25
Aethlon Medical Inc, Recent Developments 25
Jul 19, 2017: Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes 25
Jun 28, 2017: Aethlon Medical Announces Fiscal 2017 Results 25
Jun 14, 2017: Aethlon Medical To Present Clinical Study Results at The BIO International Convention 27
Apr 24, 2017: Aethlon Medical Releases Shareholder Update 27
Mar 13, 2017: Aethlon Medical Announces The Conclusion Of Hemopurifier Clinical Study 28
Mar 01, 2017: Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes 29
Mar 01, 2017: Aethlon Medical Announces the Grant of a European Patent Protecting Methods of Quantifying Exosomes 29
Feb 22, 2017: Aethlon Medical Reports Results of Cytomegalovirus, Epstein-Barr and Herpes Simplex Virus Studies 29
Feb 10, 2017: Aethlon Medical Announces Fiscal 2017 Third Quarter Results 30
Jan 25, 2017: Researchers Announce Plans for Study of Candidate Blood Test to Detect Chronic Traumatic Encephalopathy in Former NFL Players 31
Appendix 33
Methodology 33
About GlobalData 35
Contact Us 35
Disclaimer 36
List of Tables
Aethlon Medical Inc Pipeline Products and Ongoing Clinical Trials Overview 4
Aethlon Medical Inc Pipeline Products by Equipment Type 5
Aethlon Medical Inc Pipeline Products by Indication 6
Aethlon Medical Inc Ongoing Clinical Trials by Trial Status 6
Aethlon Medical Inc, Key Facts 8
Aethlon Medical Inc, Major Products and Services 9
Aethlon Medical Inc Number of Pipeline Products by Development Stage 10
Aethlon Medical Inc Pipeline Products Summary by Development Stage 11
Aethlon Medical Inc Ongoing Clinical Trials by Trial Status 12
Aethlon Medical Inc Ongoing Clinical Trials Summary 13
ASEPSYS Device - Product Status 14
ASEPSYS Device - Product Description 14
Diagnostic Test - Chronic Traumatic Encephalopathy - Product Status 15
Diagnostic Test - Chronic Traumatic Encephalopathy - Product Description 15
Diagnostic Test - Chronic Traumatic Encephalopathy - Clinical Study Involving Retired NFL Players and Data-supported Bio-marker Candidate to Detect and Monitor Chronic Traumatic Encephalopathy 16
Diagnostic Test - Chronic Traumatic Encephalopathy - Diagnosing and Evaluating Traumatic Encephalopathy using Clinical Tests 16
ELLSA Exosome Assay - Product Status 17
ELLSA Exosome Assay - Product Description 17
Hemopurifier - Product Status 18
Hemopurifier - Product Description 18
Hemopurifier - Plasma Exosome Concentration in Cancer Patients Undergoing Treatment 19
Hemopurifier - Sepsis-related Virus Study of Aethlon Hemopurifier 19
HER2osome - Product Status 20
HER2osome - Product Description 20
Aethlon Medical Inc, Key Employees 22
Aethlon Medical Inc, Key Employee Biographies 23
Aethlon Medical Inc, Subsidiaries 24
Glossary 34
List of Figures
Aethlon Medical Inc Pipeline Products by Equipment Type 5
Aethlon Medical Inc Pipeline Products by Development Stage 10
Aethlon Medical Inc Ongoing Clinical Trials by Trial Status 12
